Department of Gastroenterology, Oslo University Hospital, Norway, Institute of Clinical Medicine, University of Oslo, Norway.
Inflamm Bowel Dis. 2012 Aug;18(8):1540-9. doi: 10.1002/ibd.21863. Epub 2011 Sep 20.
Ulcerative colitis (UC) negatively affects health-related quality of life (HRQoL), but population-based and long-term data on this topic are scarce. Our aim was to determine the HRQoL in UC patients after a 10-year disease duration.
UC patients from a population-based inception cohort met at a prescheduled 10-year follow-up visit. In addition to a clinical examination, interview, and blood samples, the patients completed the Short Form 36 (SF-36) and the Norwegian Inflammatory Bowel Disease Questionnaire (N-IBDQ). The SF-36 scores were compared to scores from a general population sample using one-sample t-tests. Standardized scores were calculated and interpreted according to Cohen's effect size index. The associations between relevant clinical and demographic factors and HRQoL were examined through linear regression analyses.
A total of 196 patients completed the HRQoL questionnaires (response rate: 80%), of whom 54% were women; the mean age of all patients was 48 years (range: 22-86). The SF-36 scores were comparable to those of the general population except for lower scores in the General Health dimension. The SF-36 scores were significantly lower in the presence of current symptoms, in patients who had used corticosteroids, and in patients who reported not working. Overall N-IBDQ scores were equivalent to scores of patients in remission. Female gender, work status (not working), current symptoms, and smoking were associated with significantly lower N-IBDQ scores.
SF-36 scores were not reduced compared to the general population sample. The presence of current symptoms, the use of corticosteroids, work status (not working), female gender, and smoking had a negative impact on HRQoL.
溃疡性结肠炎(UC)会对健康相关生活质量(HRQoL)产生负面影响,但关于这一主题的基于人群和长期数据却很少。我们的目的是确定 UC 患者在患病 10 年后的 HRQoL。
从基于人群的发病队列中招募 UC 患者,并在预定的 10 年随访时进行检查。除了临床检查、访谈和血液样本外,患者还完成了简明健康调查问卷 36 项(SF-36)和挪威炎症性肠病问卷(N-IBDQ)。使用单样本 t 检验将 SF-36 评分与一般人群样本的评分进行比较。根据 Cohen 的效应大小指数计算和解释标准化评分。通过线性回归分析,研究了与 HRQoL 相关的临床和人口统计学因素之间的关联。
共有 196 名患者完成了 HRQoL 问卷调查(应答率:80%),其中 54%为女性;所有患者的平均年龄为 48 岁(范围:22-86 岁)。SF-36 评分除了在总体健康维度上的评分较低外,与一般人群的评分相当。当前存在症状、使用过皮质类固醇以及报告未工作的患者的 SF-36 评分明显较低。总体而言,N-IBDQ 评分与缓解期患者的评分相当。女性、工作状态(不工作)、当前症状和吸烟与较低的 N-IBDQ 评分显著相关。
SF-36 评分与一般人群样本相比并未降低。当前存在症状、使用皮质类固醇、工作状态(不工作)、女性和吸烟对 HRQoL 有负面影响。